Category:

Pandemic

Latest

Covid-19 vaccine: India looking at USD 11 bn market opportunity

According to CARE Ratings, the majority of domestic demand is expected to be fulfilled by March 2022, when the export opportunities in the high-income markets such as Europe, North America, and developed Asian countries are likely to be completely exhausted.

However, the export opportunities in various African, Asian excluding China and Japan and some South American countries, where the pace of vaccination remains very slow would still exist, which is expected to remain greater than 1.25 billion doses, it said.

read more

Fewer women than men will regain work during COVID-19 recovery: ILO 

In Building Forward Fairer: Women’s rights to work and at work at the core of the COVID-19 recovery, the International Labour Organization (ILO) highlights that between 2019 and 2020, women’s employment declined by 4.2 per cent globally, representing 54 million jobs, while men suffered a three per cent decline, or 60 million jobs. 

read more

Pandemic has IFC pumping $1.7 billion into local companies, up 51%

The impact of the pandemic coupled with the region’s vulnerability to climate change, has highlighted the need for a collaborative, resilient and climate friendly recovery that can withstand future shocks, said its new regional director for South Asia, Hector Gomez Ang.

While South Asia is one of the fastest growing regions in the world, estimates suggest that climate impacts could reduce its annual GDP by an average of 1.8 percent by 2050, rising to 8.8 percent by 2100 if the region failed to take adequate corrective measures. The region is also estimated to have an untapped climate investment potential of USD3.4 trillion by 2030, Ang said.

read more

No data shows need for booster vaccines presently: Dr Gagandeep Kang

According to Dr Kang, whether people will have more antibodies or be better protected with the booster dose is still not known.

“It sounds obvious that more antibodies (abs) are better but we really don’t know whether people who push up abs with additional doses will be better protected than with the level they initially made. Or that when abs wane, we need to boost to maintain above some level,” she said.

Further, she explained how people with a poor immune response should get a third dose,

read more

Claim and counter-claim: health insurance key point of debate in pandemic

Health insurance companies received a total of 23.06 lakh claims from April 2020 till August 6, 2021, of which 13.19 lakh claims worth Rs 14,783 crore were received since April 1 this year, it said.

But why are claims being rejected? Giving the flip side of the picture, companies in the business said there are various reasons, including patients hiding pre-existing conditions or raising a claim before the waiting period of certain days after purchasing a policy.

read more

Biz activity last week higher than pre-COVID level for first time: Report

This is the first time that the activity has breached the pre-pandemic base. The index level had declined sharply in the immediate aftermath of the national lockdown in April last year and rose steadily to be very close to the pre-pandemic levels of March 2020. However, the second wave and the ensuing localised lockdowns dented it again, till it rose after the waning of the infections.

read more